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The recent outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a global
crisis, necessitating the identification of genetic factors that modulate the risk of disorder or its severity. The
current data about the role of genetic risk factors in determination of rate of SARS-CoV-2 infection in each ethnic
group and the severity of disorder is limited. Moreover, several confounding parameters such as the number of
tests performed in each country, the structure of the population especially the age distribution, the presence of
risk factors for respiratory disorders such as smoking and other environmental factors might be involved in the
variability in disease course or prevalence of infection among different ethnic groups. However, assessment of
the role of genetic variants in determination of the course of other respiratory infections might help in re-
cognition of possible candidate for further analysis in patients affected with SARS-CoV-2. In the current review,
we summarize the data showing the association between genomic variants and risk of acute respiratory distress
syndrome, respiratory infections or severity of these conditions with an especial focus on the SARS-CoV-2.
1. Introduction
The recent pandemic of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has caused the coronavirus disease 2019
(COVID-19) and created a global crisis, devastating health organiza-
tions and perplexing researchers to find the solution for this problem.
Meanwhile, it has raised the question whether genetic factors can de-
fine the susceptibility to the disorder or the severity of symptoms.
Although few studies have tried to answer the question [1], it seems to
be too early to reach a conclusive results in this regard. Yet, previous
studies have indicated that susceptibility to respiratory tract infections
is determined by both genetic and acquired risk factors [2]. As SARS-
CoV-2 exploits angiotensin converting enzyme 2 (ACE2) for its entrance
inside the cells, this gene is a putative risk factor for this infection [3,4].
Being located in a genomic region on chromosome X that escapes from
X inactivation, it has a heterogeneous sex bias expression in different
tissues [5]. Higher levels of its expression in male tissues has been
attributed to 17β-estradiol-dependent and sex chromosome-in-
dependent mechanisms [6]. Fig. 1 shows the role of some polymorph-
isms is ACE2 and other genes in the course of SARS-CoV-2 infection.
In the current review, we conducted a comprehensive search to find
the genetic variants that modify the risk of respiratory tract infections
with especial focus on viral infections. We summarize the data showing
the association between genomic variants and risk of these infections or
severity of the disorder.
2. SARS-CoV
Itoyama et al. have investigated the role of ACE1 insertion/deletion
(I/D) polymorphism in conferring risk of SARS or disease course in the
Vietnamese individuals. They reported higher frequency of the D allele
in the hypoxemic group compared with the non-hypoxemic group.
However, there was no remarkable difference in the frequency of these
alleles between the SARS-CoV cases and non-affected individuals,
https://doi.org/10.1016/j.biopha.2020.110296
Received 28 April 2020; Received in revised form 16 May 2020; Accepted 19 May 2020
⁎ Corresponding authors.
E-mail addresses: mohammad_823@yahoo.com (M. Taheri), nfsanak@cyf-kr.edu.pl (M. Sanak).
1 Contributed equally to this work.
Biomedicine & Pharmacotherapy 128 (2020) 110296
0753-3322/ © 2020 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
T
regardless of the contact history. Thus, ACE1 has been suggested as a
candidate locus for determination of the course of SARS in the assessed
population [10]. Tu et al. genotyped the CCL2 G-2518A and MBL codon
54 variant (A/B) in four populations of Chinese patients with SARS and
healthy subjects. They reported association between the high-CCL2-
producing GG genotype and the low-MBL-producing B allele and higher
susceptibility to SARS-CoV infection in all cohorts. Yet, there was no
association between these variants and severity of SARS [7]. Lau et al.
have shown association between the IFN-γ +874A allele and RANTES
−28 G allele and risk of SARS-CoV infection. The RANTES−28 G allele
has also been shown to participate in the pathophysiology of this in-
fection. However, the assessed SNPs of IL-10, TNF-α, IL-12, IP-10, Mig
and MCP-1 were not linked with the risk of SARS-CoV [11]. Yuan et al.
have we evaluated a certain SNP in CD14 gene in a population of SARS
patients who were formerly genotyped for FcγRIIA SNPs. They found
higher frequency of the CD14-159CC SNP and severe SARS. Both CD14-
159CC and FcγRIIA-RR131 SNPs were described as susceptibility fac-
tors for severe SARS-CoV infection [12]. Based on the previously re-
ported effects of CD209 in the promotion of SARS-CoV spike protein-
bearing pseudotype associated infection in permissive cells, Chan et al.
have assessed association between a variant within this gene and clin-
ical outcome of patients with SARS-CoV infection. SARS patients who
carry the −336AG/GG genotype had lower standardized lactate-de-
hydrogenase (LDH) levels and poorer outcome compared with the
−336AA patients [13]. Besides, Lin et al. have assessed association
between HLA alleles and SARS-CoV infection in Asian population. HLA-
B*4601 and HLA-B*5401 were reported as the most probable factors in
conferring risk of infection, when comparing infected SARS patients
and high risk health care workers individuals. The severity of SARS-CoV
infection was correlated with HLA-B*4601 [14].
3. SARS-CoV-2
Asselta et al. have recently investigated the putative genetic ele-
ments of the strange severity of COVID-19 among Italians. They have
observed the transcript levels and genetic polymorphisms in ACE2 and
TMPRSS2 genes, which have been shown to be involved in the process
of viral infection. They have assessed the data of exome and single
nucleotide polymorphism (SNP) array in a large cohort of Italian in-
dividuals as an illustrative model of the whole population. Then, they
compared the presence of rare variants and the occurrence of SNPs with
Europeans and East Asians. Besides, they searched the gene expression
catalogues to examine the sex-biased expression. Surprisingly, they
detected no remarkable clue for association between ACE2 and COVID-
19 severity/sex bias in the Italian population. Yet, expression levels and
SNPs of TMPRSS2 were identified as putative modulators of this dis-
order explaining the reported statistics among Italian patients. Yet, the
obtained results should be verified through experimental analyses in
large sample sizes of affected individuals with various clinical pre-
sentations [1]. Renieri et al. have retrieved the exome data of 7000
individuals from the Network of Italian Genomes to assess the ACE2
variants. They recognized some variants with a potential effect on the
stability of the ACE2 protein. Three missense variants with minor allele
frequencies between 0.002 and 0.015 were anticipated to alter protein
cleavage and stabilization. The variants p.Asn720Asp, p.Lys26Arg,
p.Gly211Arg have not been detected in the Eastern Asia population.
They also detected rare truncating variants that modulate the inter-
nalization course and one missense variant (p.Trp69Cys) which was
anticipated to alter the process of SARS-CoV-2 spike protein binding.
Although not verified by experimental assays, these SNPs might parti-
cipate in the detected inter-individual difference in the severity of
disorder [3]. Cao et al. have assessed the functional role of 1700 ACE2
Fig. 1. ACE2 gene is located on chromosome X, in a genomic region which escapes from X inactivation. Yet, it has a heterogeneous sex bias expression in different
tissues [5]. The AA genotype of the rs2285666 is associated with higher expression of ACE2. Based on the role of ACE2 as the cell receptor for entrance of the virus,
the mentioned polymorphism might affect the infection course [1]. The rs1024611 is located in the transcript start site of the CCL2 gene and might affect expression
of the corresponding gene. The GG genotype of this polymorphism is associated with higher levels of CCL2. CCL2 is a chemokine that regulates chemotaxis and
secretion of inflammatory mediators from monocytes and macrophages [7]. The rs2070874 polymorphism is located in the 5' UTR of IL-4 gene and might influence
transcription of this gene [8]. IL-4 down-regulates ACE2 receptor, thus preclude SARS-CoV entrance into the cells [9].
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3
variants. They reported no indication of the presence of coronavirus S-
protein binding-resistant ACE2 mutants in various ethnic groups. The
East Asian populations were shown to have higher allele frequencies in
the eQTL variants correlated with elevated expression of ACE2 in tis-
sues. Thus, they conclude the role of these variants in the inter-popu-
lation variability in the risk of SARS-CoV-2 infection or host response to
this virus [15].
4. Influenza
Cheng et al. have assessed the role of possible genetic factors that
influence the risk of severe H1N1 and H7N9 Influenza infections. They
conducted a pilot genome-wide association study (GWAS) and a sub-
sequent assessment of the expression quantitative trait locus (eQTL)
data set in the lung tissue. They recognized the GG genotype of
rs2070788 in TMPRSS2 as a risk factor of severe H1N1 infection. This
variant has been associated with elevated expression of TMPRSS2. They
also identified a putative functional SNP namely rs383510 which tags
with rs2070788. Functional studies confirmed the regulatory role of
rs383510 on TMPRSS2 expression in a genotype-specific mode. Both
SNPs were associated with the risk of H7N9 influenza. Taken together,
SNPs that increase TMPRSS2 expression are regarded as risk variants
for severe H1N1 influenza. Moreover, these variants confer risk of
H7N9 influenza [16]. Zhou et al. have shown association between the
rs2564978 genotype T/T of CD55 and severe H1N1 infection. They also
reported an allele-specific impact on CD55 expression which was at-
tributed to a promoter indel variation located in the complete linkage
disequilibrium with rs2564978. CD55 can guard epithelial cells of the
respiratory system from complement harm. Moreover, the H1N1 in-
fection enhanced CD55 expression [17]. Moreover, To et al. have re-
ported an association between the C allele of rs1130866 in the surfac-
tant protein B gene (SFTPB) and severe H1N1 disease [18].
5. Respiratory syncytial virus (RSV)
Alvarez et al. reported association between SNP rs2107538 of CCL5
and bronchiolitis caused by RSV. In addition, the rs4986790 of TLR4,
rs1898830 of TLR2, and rs2228570 of VDR were regarded as risk fac-
tors for progression to death [19]. Löfgren et al. have shown association
between the Gly299Gly genotype of TLR4 and protection against severe
RSV during the year 2000 epidemics. Yet, they did not verify the as-
sociation between the Gly299 allele and severe RSV probably due to the
effect of environmental and constitutional parameters in determination
of susceptibility to severe RSV infection [20].
6. Acute respiratory distress syndrome (ARDS)
Meyer et al. have reported association between the IL1RN SNP
rs315952 C allele and lower risk of ARDS in three distinct group of
patients with different ARDS risk factors. Notably, this variant was
associated higher plasma IL1RA response. IL1RA has been shown to
reduce ARDS risk [21]. Liu et al. have shown association between
elevated interleukin (IL)-10 levels and two SNPs (-592 C and -819 C) at
the promoter region of the corresponding gene. Notably, in patients
with ARDS, there was a significant association between IL-10 levels at
the time of installation of extracorporeal membrane oxygenation and
poor prognosis [22]. Gong et al. also verified the association between
the −1082 GG genotype of IL-10 and development of ARDS. Yet, this
genotype had a significant interaction with age. Among patients with
ARDS, this genotype was associated with reduced severity of disorder
on admission as well as deceased mortality and organ damage. Thus,
the high IL-10-producing −1082 GG genotype may be related to dif-
ferent risk values of ARDS depending on age [23]. However, in a po-
pulation of patients with community acquired pneumonia, the
−1082 G allele was associated with higher expression of IL-10 and
increasing severity of the condition [24]. Ding et al. have demonstratedTa
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associations between the TNF-α rs1800629 A allele and the IL-6
rs1800796 G allele and higher susceptibility to ARDS. Moreover, they
reported a protective role for the G allele at MyD88 rs7744 against
ARDS. These SNPS have been shown to influence the survival rate of
patients as well [25].
Table 1 summarizes the results of studies which appraised the role
of SNPs in susceptibility to respiratory disorders or the severity of these
conditions.
7. Discussion
With the progression of the COVID-19 pandemic, the need for
identification of prognostic biomarkers for susceptibility to severe dis-
ease is emerging. The current data about the role of genetic risk factors
in the determination of rate of SARS-CoV-2 infection in each ethnic
group and the severity of disorder is limited and is not validated by
experimental assays. Moreover, several confounding parameters such as
the number of tests performed in each country, the structure of the
population especially the age distribution, the presence of risk factors
for respiratory disorders such as smoking and other environmental
factors might be involved in the variability in disease course or pre-
valence of infection among different ethnic groups [1]. Yet, assessment
of the obtained data of association between genetic variants and other
relevant viruses such as SARS-CoV might be helpful in this regard.
Notably, several genetic loci have been shown to influence the risk of
ARDS, a condition which is associated with severe COVID-19 infection.
Thus, these genetic variants might also modulate the progression of
COVID-19 in the affected patients. These SNPs mostly affect the levels
of pro-inflammatory and anti-inflammatory cytokines. However, the
results of these studies should be verified in different ethnic groups.
Moreover, a number of variants have been associated with more than
one of the mentioned disorders. For instance, the rs2070788 of
TMPRSS2 is associated with SARS-CoV2 as well as influenza. Similarly,
rs1800629 of TNFα is associated with ARDS as well as sepsis. Besides,
rs1800896 is associated with higher levels of IL-10, ARDS, severity of
community acquired pneumonia (CAP) and septic shock from Pneu-
mococcal diseases. The rs2430561 of IFNγ is associated with pulmonary
tuberculosis and SARS. Finally, the rs1130866 of SFTPB has been as-
sociated with severity of CAP and influenza. These data indicate the
role of these variants in defining the host response to a these infections
which is probably exerted through modulation of immune responses.
There is a necessity for conduction of inclusive investigations that
integrate genomic information, epidemiological statistics, and medical
records of the clinical manifestation of patients with COVID-19. The
final conclusive results are expected to obtain from application of a
systems biology approach to assess the data of high throughput se-
quencing methods. These results permit conduction of an evidence-
based risk assessment and the subsequent implementation of preventive
and therapeutic modalities in a personalized manner.
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